Status: Single
City: VA; CA ; NY; NV; AZ;
State: Bayern
Country: DE
Signup Date: 3/4/2006
|
|
|
|
Tuesday, October 27, 2009
|
| “The vaccine market is booming,” says Bruce Carlson, spokesperson at market research firm Kalorama, which publishes an annual survey of the vaccine industry. “It’s an enormous growth area for pharmaceuticals at a time when other areas are not doing so well.” mercola.com |
The Different Shots
In the first part of this blog I will reveal the manufacturers that
dispense their H1N1 vaccines to Europe and what kind of toxic
substances are in them. Secondly, I will home in on those substances
and expand on the nature of their respective toxicities.
 "Flu-pandemic - that's how we keep a lid on flu" (liberal translation, the original is punny) As I was browsing the internet searching for official Dutch information on the H1N1 flu circus, the website called grieppandemie.nl caught my eye: The “Veiligheid van het vaccin” (Safety of the vaccine) section, translates to:
| Safety of the Vaccine
The vaccines that are currently being deployed have been developed
over the last couple of years for the purpose of protecting against a
variant of the virus that is now causing the flu-pandemic. The active
component of the vaccine responsible for working specifically against
this flu, the so-called antigen, has to be adapted. These adapted vaccines have to satisfy strict safety requirements for registration before they can be deployed.
The registration procedures for the new vaccins Foceteria and Pandemrix are currently pending with the European Medicines Agency (EMEA). The EMEA is an institute of the European Union, that oversees the safety of new medications. To this end, it demands high standards of safety requirements. grieppandemie.nl |
 So the EMEA is the agency to turn to in finding out what is in
vaccines destined for member states of the EU. In addition to the
Focetria (Novartis) and Pandemrix (GlaxoSmithKline) vaccines already
approved for Europe, the EMEA also recommends another, supposedly
adjuvant-free, vaccine called Celvapan from Baxter:
The EMEA writes:
The European Medicines Agency has recommended to the European
Commission that an additional vaccine against influenza A(H1N1) (‘swine
flu’), Celvapan from Baxter, be granted a marketing authorisation. Adoption of an authorisation decision by the European Commission is expected shortly.
This recommendation follows the authorisation of Focetria, from
Novartis, and Pandemrix, from GlaxoSmithKline, by the European
Commission on 29 September 2009.
As for Focetria and Pandemrix, this recommendation will allow the
manufacturer to replace the flu virus strain in the current ‘mock-up’
vaccine with the A(H1N1)v strain causing the current pandemic.
Celvapan is a non-adjuvanted vaccine. This means that
it does not contain ‘adjuvants’ to enhance the immune response. The
Committee for Medicinal Products for Human Use (CHMP) is currently
recommending a two-dose vaccination schedule, at an interval of three
weeks, for adults, including pregnant women, and for children from six
months of age. Clinical trials in adults and in children are ongoing,
and more results will become available from mid-October 2009 onwards.
emea.europa.eu |
Let’s first find out what’s in these first two vaccines, Focetria and Pandemrix, that have already been approved for use in Europe. Since it is emphasized in the above EMEA website excerpt that Celvapan contains no adjuvants, it is suggested that the other two do.
Focetria (Novartis)
From the English package leaflet we read:
What Focetria contains
- Active Substance:
Influenza virus surface antigens (haemagglutinin and neuraminidase)* of strain:
A/California/7/2009 (H1N1)v like strain (X-179A) 7.5 micrograms** per 0.5 ml dose
* propagated in eggs
** expressed in microgram haemagglutinin.
This vaccine complies with the WHO recommendation and EU decision for the pandemic.
- Adjuvant:
The vaccine contains an ‘adjuvant’ (MF59C.1) to stimulate a better
response. MF59C.1 is an oil/water emulsion containing 9.75 mg squalene, 1.175 mg polysorbate 80 and 1.175 mg sorbitan trioleate in a citrate buffer.
- Other Ingredients:
The other ingredients are: thiomersal
(multidose vial only), sodium chloride, potassium chloride, potassium
dihydrogen phosphate, disodium phosphate dihydrate, magnesium chloride
hexahydrate, calcium chloride dihydrate, sodium citrate, citric acid
and water for injections.emea.europa.eu
Nederlandse bijsluiter
Leaflets in other languages |
Pandemrix (GlaxoSmithKline)
From the package leaflet we learn:
What Pandemrix contains
• Active substance:
Split influenza virus, inactivated, containing antigen* equivalent to:
A/California/7/2009 (H1N1)v-like strain (X-179A) 3.75 micrograms** per 0.5 ml dose
*propagated in eggs
** expressed in microgram haemagglutinin
This vaccine complies with the WHO recommendation and EU decision for the pandemic.
• Adjuvant:
The vaccine contains an ‘adjuvant’ AS03 to stimulate a better response. This adjuvant contains
squalene (10.69 milligrams), DL-α-tocopherol (11.86 milligrams) and polysorbate 80 (4.86
milligrams).
• Other ingredients:
The other ingredients are: polysorbate 80, octoxynol 10, thiomersal, sodium chloride, disodium
hydrogen phosphate, potassium
emea.europa.eu
Nederlandse bijsluiter
Leaflets in other languages |
Celvapan (Baxter)
The leaflet package reveals:
What Celvapan contains
Active substance:
Whole virion influenza vaccine, inactivated, containing antigen of pandemic strain*:
A/California/07/2009 (H1N1) 7.5 micrograms**
per 0.5 ml dose
* propagated in Vero cells (continuous cell line of mammalian origin)
** haemagglutinin
This vaccine complies with the WHO recommendation and EU decision for the pandemic.
Other ingredients:
The other ingredients are: trometamol, sodium chloride, water for injections, polysorbate 80.
emea.europa.eu
Nederlandse bijsluiter
Leaflets in other languages |
The Different Poisons
In the second section of this blog I indicate the nature of the toxicity (read: health risks) of the substances referenced in the previous section.
Mercury (Thimerosal or Thiomersal)
What is this stuff?
Here are two quotes from the CDC and the National Academies stating that thimerosal in vaccines is basically all fine and dandy:
Thimerosal
“Thimerosal is a mercury-containing preservative used in some vaccines and other products since the 1930s. No harmful effects have been reported from thimerosal at doses used in vaccines,
except for minor reactions like redness and swelling at the injection
site. However, in July 1999, the Public Health Service (PHS) agencies,
the American Academy of Pediatrics (AAP), and vaccine manufacturers
agreed that thimerosal should be reduced or eliminated in vaccines as a
precautionary measure. Today, with the exception of some influenza
(flu) vaccines, none of the vaccines used in the U.S. to protect
preschool children against 12 infectious diseases contain thimerosal as
a preservative.” Centers for Disease Control and Prevention
“Based on a
thorough review of clinical and epidemiological studies, neither the
mercury-based vaccine thimerosal nor the measles-mumps-rubella (MMR)
vaccine are associated with autism… Five large epidemiological studies
in the United States, the United Kingdom, Denmark, and Sweden since
2001 consistently provided evidence that there is no association
between thimerosal-containing vaccines and autism… ” National Academies press release about the IOM report “Immunization Safety Review: Vaccines and Autism,” May 18, 2004
vaccineinformation.org |
Regarding the first quote, if “no harmful effects have been reported
from thimerosal at doses used in vaccines” then, while reading the next
sentence, why promote the push to eliminate it from vaccines? The quote
of and by itself by its mere formulation is oxymoronic and therefore
suspicion raising.
Here’s a Material Safety Data Sheet of thimerosal:
Primary Physical and Health Hazards: Skin Permeable. Toxic. Mutagen. Irritant (eyes).
Allergen. Nervous System and Reproductive Effects.
Caution Statement: Thimerosal may enter the body through the skin, is toxic, alters genetic material,
may be irritating to the eyes, and causes allergic reactions. Effects
of exposure may include numbness of extremities, fetal changes,
decreased offspring survival, and lung tissue changes.
Routes of Entry: Inhalation and skin absorption.
Effects of Overexposure: Topical allergic dermatitis has been reported. Thimerosal contains
mercury. Mercury poisoning may occur and topical hypersensitivity reactions may be seen. Early signs
of mercury poisoning in adults are nervous system effects, including narrowing of the visual field and
numbness in the extremities. Exposure
to mercury in utero and in children may cause mild to severe mental
retardation and mild to severe motor coordination impairment. Based on animal data, may be irritating to the eyes. putchildrenfirst.org |
Here’s a reference by a manufacturer of thimerosal ( Sigma and Aldrich), given in the below picture, that provides it with T+,N hazard coding. So what’s the meaning of these codes? The pictograms and hazard codes page indicates that T+ stands for “Extremely toxic” and N stands for “Dangerous for the environment.” Does that sound like stuff you want to have injected straight into your system? Here is a portion of the abstract of a new peer-reviewed
scientific study investigating thimerosal neurotoxicity. It states
quite clearly that thimerosal induces autism-like neurotoxicity:
| Thimerosal-induced cellular damage as evidenced by concentration-
and time-dependent mitochondrial damage, reduced oxidative-reduction
activity, cellular degeneration, and cell death in the in vitro human
neuronal and fetal model systems studied. Thimerosal at low nanomolar
(nM) concentrations induced significant cellular toxicity in human
neuronal and fetal cells. Thimerosal-induced cytoxicity is
similar to that observed in AD pathophysiologic studies. Thimerosal was
found to be significantly more toxic than the other metal compounds
examined.informaworld.com |
Now compare this new find with the embarrassing position the CDC still maintains:
| Recent estimates from CDC’s Autism and Developmental Disabilities Monitoring network
found that about 1 in 150 children have an ASD. This estimate is higher
than estimates from the early 1990s. Some people believe increased
exposure to thimerosal (from the addition of important new vaccines
recommended for children) explains the higher prevalence in recent
years. However, evidence from several studies examining trends
in vaccine use and changes in autism frequency does not support such an
association. Furthermore, a scientific review*
by the Institute of Medicine (IOM) concluded that “the evidence favors
rejection of a causal relationship between thimerosal-containing
vaccines and autism.” CDC supports the IOM conclusion. cdc.gov |
Somebody better tell the CDC that thimerosal in vaccines is bad news after all. I doubt if they care to listen though.
In reference to the above new study one may argue that the study is an in vitro study and that to have a more accurate reflection of reality one should consider an in vivo study. In vitro here means direct application of mercury to the brain tissues examined. In vivo
means here that the mercury is administered through needle into the
bloodstream (of a living person). It depends on the strength of the
blood-brain barrier whether or not this mercury will actually reach and
affect the brain. So the practical difference between an in vitro experiment and an in vivo experiment in this case is the blood-brain barrier
(BBB), which if working to satisfaction should be able to obstruct
thimerosal present in the blood from reaching the brain and so prevent
it from doing damage. This assumption however is obviously unjustified if and when the BBB
is not working properly and as such is incapable of blocking mercury
from entering the brain. So when is the BBB compromised? For one, the
BBB is not fully functional in infants. Other reasons are given by Dr
Blaylock:
Therefore, for the many people who have an impaired BBB, exposure to
intravenously administered thimerosal does make them vulnerable to
develop autism-like disorders or symptoms.
For a more detailed narrative on how mercury and mercurial compounds
cause brain inflammation that may trigger Autism-like symptoms please
read the Appendix of Toxic Mercury. Squalene
What is this stuff?
Squalene is a natural organic compound originally obtained for commercial purposes primarily from shark liver oil, though botanic sources (primarily vegetable oils) are used as well, including amaranth seed, rice bran, wheat germ, and olives. All higher organisms produce squalene, including humans. It is a hydrocarbon and a triterpene. Squalene is a natural and vital part of the synthesis of cholesterol, steroid hormones, and vitamin D in the human body.[1] Squalene is used in cosmetics, and more recently as an immunologic adjuvant in vaccines.
Wikipedia (Squalene) |
Looks pretty benign, no? Well, that seems to be the case if you
consume it through regular channels, that is by eating or drinking it.
The situation changes unfortunately when you have the stuff injected
straight into your system. Now the substance suddenly is being
perceived far from benign. You see when injected, squalene is then registered by your immune system as a foreign substance, i.e.
something that should not be there. As a consequence, an immune
response is triggered, meaning that your immune system will proceed
with attacking squalene. Unfortunately for you, squalene is not just present in the blood
after you’ve received the flu shot. Squalene is also built-in into
various nervous tissues across your body, including brain. So when your
immune system attacks squalene it will also start attacking those
bodily structures that have squalene incorporated in them as building
blocks. That is, your own immune system becomes your own enemy. This is
the essence of an autoimmune disease like for instance Gulf War Syndrome:
| Data published in the February 2000 and August 2002 issues of Experimental and Molecular Pathology strongly suggests that Gulf War Syndrome is caused by a vaccine contaminated with squalene.
The August 2002 article is entitled “Antibodies to Squalene in
Recipients of Anthrax Vaccine” (Exp. Mol. Pathol. 73,19-27 (2002)).
Gulf War Syndrome, or GWS, is the term which has been applied to the
multi-symptom rheumatic disorder experienced by many veterans of the
1990-1991 Persian Gulf war. A similar disorder appeared in
1990-1991-era personnel who were never deployed to the Persian Gulf
theater of operations and also in other military personnel, including
participants in the Anthrax Vaccine Immunization Program, or AVIP,
which was inaugurated in 1997. No data has ever suggested that the
disorder experienced by the deployed 1990-1991 soldiers is different
from the disorder experienced by the other groups of patients, but the
other cases have not been considered to be cases of GWS.
Squalene was found by the U.S. Food and Drug Administration in five
lots of the AVIP anthrax vaccine. The discovery of serum anti-squalene
antibodies and the development of a test to detect these antibodies has
made it possible to see that links appear to exist between the
contaminated AVIP vaccine lots, the illness experienced by post-1997
vaccine recipients, the illness experienced by non-deployed
1990-1991-era patients, and the illness in deployed 1990-1991-era
patients that has been referred to as GWS.
The data establishing these links is presented in the peer-reviewed
February 2000 and August 2002 articles. The published findings (1)
strongly suggest that the GWS-like illness being reported by all of the
various patient groups is the same illness, (2) strongly suggest that
the contaminated vaccine caused the illness in the AVIP group, and (3) further suggest that squalene contamination of one or more 1990-1991-era vaccines accounts for the GWS cases from that era. autoimmune.com |
 Here’s the abstract of a scientific study which shows that Gulf War
era troops suffering from GWS, whether or not they were deployed in the
actual Gulf War, almost all had antibodies to squalene:
Antibodies to squalene in Gulf War syndrome.
Asa PB, Cao Y, Garry RF.
Department of Microbiology, Tulane Medical School, 1430 Tulane Avenue, New Orleans, Louisiana, 70112, USA. PMBA@aol.com
Gulf War Syndrome (GWS) is a multisystemic illness afflicting many
Gulf War-era veterans. The molecular pathological basis for GWS has not
been established. We sought to determine whether the presence of
antibodies to squalene correlates with the presence of signs and
symptoms of GWS. Participants in this blinded cohort study were
individuals immunized for service in Desert Shield/Desert Storm during
1990-1991. They included 144 Gulf War-era veterans or military
employees (58 in the blinded study), 48 blood donors, 40 systemic lupus
erythematosus patients, 34 silicone breast implant recipients, and 30
chronic fatigue syndrome patients. Serum antibodies to squalene were
measured. In our small cohort, the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene.
Neither patients with idiopathic autoimmune disease nor healthy
controls had detectable serum antibodies to squalene. The majority of
symptomatic GWS patients had serum antibodies to squalene. Copyright
2000 Academic Press.
ncbi.nlm.nih.gov (pubmed) |
Polysorbate 80 (TWEEN 80)
What is this stuff?
| Polysorbate 80
Polysorbate 80 (commercially also known as Tween® 80) is a nonionic detergent and emulsifier derived from sorbitol and oleic acid,
and is often used in foods, especially pickles. Polysorbate 80 is a
viscous water soluble yellow liquid. The hydrophilic groups in this
compound are polyethers which are polymers of ethylene oxide.
Polysorbate 80 is often used in ice cream to prevent milk proteins
from completely coating the fat droplets. This allows them to join
together in chains and nets, to hold air in the mixture, and provide a
firmer texture, holding its shape as the ice cream melts.
Other names
Polyoxyethylene sorbitan monooleate
(x)-sorbitan mono-9-octadecenoate poly(oxy-1,2-ethanediyl) medic8.com |
Can it do harm? Yes, it can:
Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions.
Coors EA, Seybold H, Merk HF, Mahler V.
Department of Dermatology, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
Polyoxyethylene-sorbitan-20-monooleate (also known as polysorbate 80
and Tween 80) is a solubilizing agent ubiquitously used in nutritives,
creams, ointments, lotions, and multiple medical preparations (e.g.,
vitamin oils, vaccines, and anticancer agents) and as an additive in
tablets. Whereas its relevance as a contact allergen has declined
during the past decades, it is of current relevance as a “hidden”
inductor of anaphylactoid reactions. OBJECTIVE: To identify polysorbate
80 (generally believed to be an inert vehicle) as an inductor of a
severe anaphylactoid reaction. METHODS: Skin prick testing,
enzyme-linked immunosorbent assay, IgE immunoblotting, and flow
cytometric detection of basophil activation were performed in controls
and in a patient with a medical history of anaphylactic shock due to
intravenous administration of a multivitamin product during pregnancy.
RESULTS: Polysorbate 80 was identified as the causative agent for the anaphylactoid reaction of nonimmunologic origin in the patient.
Polysorbate specific IgE antibodies were not identified in
enzyme-linked immunosorbent assay and immunoblot examinations,
confirming the nonimmunologic nature of the anaphylactoid reaction.
CONCLUSIONS: Polysorbate 80 is a ubiquitously used solubilizing agent that can cause severe nonimmunologic anaphylactoid reactions.
ncbi.nlm.nih.gov (pubmed) |
 In addition to the risk of inducing anaphylactic shock, it has been
demonstrated by a 1993 Slovakian study that TWEEN 80 damages fertility
in rats:
Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats.
Gajdová M, Jakubovsky J, Války J.
Institute of Preventive and Clinical Medicine, Limbová, Bratislava.
Neonatal female rats were injected ip (0.1 ml/rat) with Tween 80 in 1, 5 or 10% aqueous solution on days 4-7 after birth. Treatment with Tween 80 accelerated maturation, prolonged the oestrus cycle, and induced persistent vaginal oestrus. The relative weight of the uterus and ovaries was decreased
relative to the untreated controls. Squamous cell metaplasia of the
epithelial lining of the uterus and cytological changes in the uterus
were indicative of chronic oestrogenic stimulation. Ovaries were without corpora lutea, and had degenerative follicles. ncbi.nlm.nih.gov (pubmed) |
Video references:
8:20 PM
Powered by  | | English | | Albanian | | Arabic | | Bulgarian | | Catalan | | Chinese | | Croatian | | Czech | | Danish | | Dutch | | Estonian | | Filipino | | Finnish | | French | | Galician | | German | | Greek | | Hebrew | | Hindi | | Hungarian | | Indonesian | | Italian | | Japanese | | Korean | | Latvian | | Lithuanian | | Maltese | | Norwegian | | Polish | | Portuguese | | Romanian | | Russian | | Serbian | | Slovak | | Slovenian | | Spanish | | Swedish | | Thai | | Turkish | | Ukrainian | | Vietnamese |
|
|
|